Home
Company
About Us
History
Certifications
Equity Structure
Products
SARS-CoV-2
Gastric Function
News
Company News
Industry Information
Media Coverage
Contact
Global
中文
News
Company News
Industry Information
Media Coverage
04-21
2021
Invited to Attend China-Spain Biomedical...
As a healthcare company proactively participating in the COVID-19 combat, Biohit (Hefei) was invited to be present at the China-Spain Biomed...
04-02
2021
CE Mark Certification Received for SARS-...
We're very pleased to announce that we have been awarded the CE marking for our SARS-CoV-2 Antigen Rapid Test (Colloidal Gold Method). ...
02-25
2021
Corporate relocation! Meet our brand-new...
Biohit (Hefei) moved to new site in the early February. This relocation is part of our strategic initiative that focuses on ope...
10-05
2020
Biohit (Hefei) SARS-CoV-2 antigen rapid ...
On September 29th, 2020, the SARS-CoV-2 antigen rapid test kit (fluorescence immunochromatography) independently developed and manufactur...
09-02
2020
The first innovative blood antigen test ...
The SARS-CoV-2 antigen quantitative assay kit (enzyme-linked immunoassay) independently developed and produced by Biohit Healthcare (Hefe...
06-19
2020
Biohit SARS-CoV-2 IgM/IgG Antibody Test ...
On March 18th, the SARS-CoV-2 IgM/IgG Antibody Test Kit(Colloidal Gold Method) produced by Biohit Healthcare(Hefei) Co., Ltd. passed the ...
06-19
2020
Biohit SARS-CoV-2 Antibody Test Kit Obta...
On June 18th 2020, Biohit SARS-CoV-2 IgM/IgG Antibody Test Kit (Colloidal Gold Method) obtained U.S. Food and Drug Administratio...
06-12
2020
Biohit SARS-CoV-2 Antigen Quantitative A...
On June 12th, the SARS-CoV-2 Antigen quantitative assay kit (enzyme-linked immunoassay) produced by Biohit Healthcare(Hefei) Co., Ltd. pa...
1
2
3
4